TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares
to which voting rights are attached (ii):
Lupus Capital plc
2. Reason for the notification (please state Yes/No): ( )
An acquisition or disposal of voting rights: (Yes)
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights
are attached: (No)
An event changing the breakdown of voting rights: (No)
Other (please specify) : (initial notification of shareholding)
3. Full name of person(s) subject to the notification obligation
(iii):
Mr G Hutchings
4. Full name of shareholder(s) (if different from 3.) (iv):
Mr G Hutchings
Alliance Trust Pensions
Lupus Employee Share Ownership Trust
5. Date of the transaction (and date on which the threshold is
crossed or reached if different) (v):
27 August 2009
6. Date on which issuer notified:
1 September 2009
7. Threshold(s) that is/are crossed or reached:
10%
8. Notified details:
None
A: Voting rights attached to shares
Class/type of shares if possible using Situation previous to the
the ISIN CODE Triggering transaction (vi)
GB0002424041 Number of Number of
shares voting Rights
(viii)
4,962,947
10,108,873
Resulting situation after the triggering transaction (vii)
Class/type of Number of Number of voting rights % of voting
shares if possible shares (ix) rights
using the ISIN CODE
Ordinary Direct Direct (x) Indirect Direct Indirect
(xi)
8,785,466 8,785,466 6.77 3.96
5,145,926
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Exercise/Conversion Number of voting % of
financial Date (xiii) Period/ Date (xiv) rights that may be voting
instrument acquired if the rights
instrument is
exercised/
converted.
N/A
Total (A+B)
Number of voting rights % of voting rights
13,931,392 10.73
9. Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable
(xv):
See 4 above
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
None
14. Contact name:
Mr G Hutchings
15. Contact telephone number:
Annex to Notification Of Major Interests In Shares (xvi)
A: Identity of the person or legal entity subject to the notification
obligation
Full name (including legal form for legal entities):
Lupus Capital plc
Contact address (registered office for legal entities):
145-157 St John Street, London EC1V 4RU
Phone number:
0207 490 4355
Other useful information (at least legal representative for legal
persons):
None
B: Identity of the notifier, if applicable (xvii)
Full name:
J L Luetchford
Contact address:
145-157 St John Street, London EC1V 4RU
Phone number:
0207 490 4355
Other useful information (e.g. functional relationship with the
person or legal entity subject to the notification obligation):
Secretary
C: Additional information :
None
---END OF MESSAGE---
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.